|Bid||42.47 x 0|
|Ask||42.62 x 0|
|Day's range||41.90 - 44.60|
|52-week range||12.96 - 44.60|
|Beta (5Y monthly)||2.33|
|PE ratio (TTM)||N/A|
|Earnings date||09 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||28.27|
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced that the Company has filed an early warning report under National Instrument 62-103 in connection with the acquisition of an option (the "Option") to purchase 1,072,450 common shares (the "Common Shares") of TerrAscend Corp. ("TerrAscend"), conditional upon the occurrence or waiver of amendments to federal laws of the United States to permit the general cultivation, distribution and possession of marijuana (as defined in 21 U.S.C 802) or to remove the regulation of such activities from the federal laws of the United States (the "Triggering Event"). Upon the occurrence or waiver of the Triggering Event, the Company may exercise the Option and pay the balance of the purchase price in order to acquire the Common Shares subject to the Option.
Cannabis companies continue to rally in 2021. The next chapter could come down to which company capitalizes on reforms, says Curaleaf Chairman Boris Jordan.
The major U.S. cannabis companies could see a big boost coming from reforms that would allow them to list on U.S. stock exchanges, according one top analyst.